Omalizumab for treatment of ABPA exacerbations in CF patients.
about
Management of allergic bronchopulmonary aspergillosis: a review and updateOmalizumab, an anti-immunoglobulin E antibody: state of the art.Omalizumab: Anti-IgE therapy in allergy.Severe asthma with fungal sensitization.Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab.Anti-IgE--emerging opportunities for Omalizumab.Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence.Use of nebulized amphotericin B in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.Management of patients with cystic fibrosis and allergic bronchopulmonary aspergillosis using anti-immunoglobulin e therapy (omalizumab).Measured immunoglobulin E in allergic bronchopulmonary aspergillosis treated with omalizumab.The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.
P2860
Q28265740-2EA4705D-4F3E-46D5-AADA-714C0635059EQ35095218-484CD359-6101-455D-BAAB-D80963C4AFF5Q37829671-C5774205-9792-40E8-A8F9-7702FFEF4210Q37905686-2BD343C5-7A0F-491A-BEF7-66D9A4605AF6Q38064439-73737991-0A37-4B50-9192-5F309FCCCDD7Q38091754-5FE869B7-0503-4EBB-8BF4-D6606DFF6551Q38156139-ECEAC4FF-CAEC-4FC3-8983-03FAA1E2F470Q41604057-21C75998-F715-4CF5-A368-E0E9B0020D0FQ42321351-DBDDC863-2CAC-4453-B99D-34C7C49AF878Q44924204-B074C171-BC18-4470-AA52-1C9A4D053A33Q46703592-91CA3BB6-3943-4DBE-A7A1-59F6C79467B0Q51118496-E1248E89-A05C-4B18-8CB7-816D1B2E1433Q51417335-E1E22D1C-3DB9-4EF8-95F9-94A4020C5B17
P2860
Omalizumab for treatment of ABPA exacerbations in CF patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Omalizumab for treatment of ABPA exacerbations in CF patients.
@en
Omalizumab for treatment of ABPA exacerbations in CF patients.
@nl
type
label
Omalizumab for treatment of ABPA exacerbations in CF patients.
@en
Omalizumab for treatment of ABPA exacerbations in CF patients.
@nl
prefLabel
Omalizumab for treatment of ABPA exacerbations in CF patients.
@en
Omalizumab for treatment of ABPA exacerbations in CF patients.
@nl
P2093
P356
P1476
Omalizumab for treatment of ABPA exacerbations in CF patients.
@en
P2093
Anissa Leonard
Charles Pilette
Patrick Lebecque
P356
10.1002/PPUL.21002
P577
2009-05-01T00:00:00Z